GLP-1 Insurance Coverage in 2026: What's Covered and How to Get Approved

The Coverage Landscape in 2026

Insurance coverage for GLP-1 medications has expanded significantly but remains inconsistent:

• Medicare: Now covers Wegovy and Zepbound for obesity (as of 2025 legislation)
• Medicaid: Varies by state — 30+ states now cover at least one GLP-1 for obesity
• Commercial insurance: Most plans cover for diabetes; obesity coverage varies widely
• Self-pay: $350-500/month for brand-name; $150-350 for compounded

Getting Prior Authorization Approved

Most insurers require prior authorization. Tips for approval:

1. Document BMI ≥30 (or ≥27 with comorbidity) in your medical records
2. Show previous weight loss attempts — document 3-6 months of diet/exercise/behavioral programs
3. Get comorbidity diagnoses on record — sleep apnea, prediabetes, hypertension, PCOS all help
4. Have your provider use specific ICD-10 codes — E66.01 (morbid obesity) is strongest

If Denied: Appeal Strategies

• Peer-to-peer review: Your doctor speaks directly with the insurance medical director
• Letter of medical necessity: Detailed letter from your provider explaining why this specific medication is needed
• External review: After internal appeals are exhausted, request state external review (required by law)
• Cite clinical guidelines: Reference AMA, Endocrine Society, and AAP guidelines that recommend pharmacotherapy for obesity

Cost-Saving Alternatives

If insurance won't cover:

• Manufacturer savings cards: Novo Nordisk and Lilly both offer copay assistance ($25-150/month with commercial insurance)
• Compounding pharmacies: $150-350/month for compounded semaglutide or tirzepatide
• Clinical trials: Free medication + monitoring (clinicaltrials.gov)
• Telehealth providers: Often negotiate better pharmacy pricing ($200-400/month all-inclusive)
• Patient assistance programs: For qualifying income levels

The Trend

Coverage is expanding year over year as cardiovascular and kidney outcome data strengthens the case. The CMS decision to cover for Medicare was a watershed moment. Most commercial plans are expected to add obesity coverage by 2027-2028 to remain competitive.